CANCER IS THE ULTIMATE ENGINEERING CHALLENGE
Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Oct 2018)
What this means for you
This application is over — abandoned 15 Oct 2018. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86725362
- Mark type
- Stylized text
- Filed
- 14 Aug 2015
- Published for opposition
- 12 Jan 2016
- Abandoned
- 15 Oct 2018
- Attorney of record
- Frances M. Jagla
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the diagnosis and treatment of cancer, oncological disorders, autoimmune disorders, inflammatory disorders, hematological disorders and dermatological disorders
Owner
- MERRIMACK PHARMACEUTICALS, INC., Cambridge, MA, US
- MERRIMACK PHARMACEUTICALS, INC., Cambridge, MA, US
Prosecution history
- 15 Oct 2018 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 15 Oct 2018 — ABANDONMENT - NO USE STATEMENT FILED
- 06 Mar 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Mar 2018 — SOU EXTENSION 4 GRANTED
- 02 Mar 2018 — SOU EXTENSION 4 FILED
- 02 Mar 2018 — SOU TEAS EXTENSION RECEIVED
- 09 Sept 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Sept 2017 — SOU EXTENSION 3 GRANTED
- 07 Sept 2017 — SOU EXTENSION 3 FILED
- 07 Sept 2017 — SOU TEAS EXTENSION RECEIVED
- 02 Mar 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Feb 2017 — SOU EXTENSION 2 GRANTED
- 28 Feb 2017 — SOU EXTENSION 2 FILED
- 28 Feb 2017 — SOU TEAS EXTENSION RECEIVED
- 09 Sept 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED